The review discusses the growing concern about cardiovascular complications arising from androgen deprivation therapy (ADT) for prostate cancer patients. These complications are not solely due to androgen suppression, as specific types of ADT lead to distinct cardiovascular issues. The purpose...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.